Vitamin K2 as Menaquinone-7 (MENAQ7) is Essential for Healthy Bone Growth and Development in Children – Study
The present study is a double-blind randomized placebo-controlled study examining the effect of 45 mcg natural vitamin K2 as menaquinone-7 (MK-7) (MenaQ7) on the circulating levels of the vitamin K-dependent protein Osteocalcin.
04/06/09 Findings of a new study published in British Journal of Nutrition 2009 by van Summeren and colleagues demonstrated that even modest supplementation with menaquinone-7 in children increases activation of osteocalcin, the bone-building protein; and in that way supports healthy bone growth and development. This is an important finding as the greater bone mineral established during childhood and early adult years, culminating in peak bone mineral density around 30 years of age, allows for better maintenance of bone health as we age and lose bone mass.
The present study is a double-blind randomized placebo-controlled study examining the effect of 45 mcg natural vitamin K2 as menaquinone-7 (MK-7) (MenaQ7) on the circulating levels of the vitamin K-dependent protein Osteocalcin. Active osteocalcin is required for bone-building cells (osteoblasts) to optimally utilize calcium for building and maintaining a healthy bone matrix. 8 weeks of MenaQ7 supplementation in healthy prepubertal children increased blood levels of vitamin K2 as MK-7 and significantly increased the amount of active osteocalcin.
According to Professor Cees Vermeer at the VitaK research center, “Non-supplemented people are generally insufficient in vitamin K. It has been demonstrated that children are far more vitamin K deficient than adults. We explain this by the rapid growth of their bones and consequently the high vitamin K demand by the bones for the production of osteocalcin. The present study is the first one to demonstrate that increased vitamin K intake by supplement improves the osteocalcin activity in children. The next step must be that also an effect of MenaQ7 on bone strength or fracture risk is demonstrated in this age group. There is a growing awareness that maximizing bone strength at childhood is an important strategy to prevent osteoporosis at later age.”
Osteocalcin is a protein responsible for utilization of calcium within bone tissue - it has the ability to bind calcium to the matrix of bones, which makes them stronger and less susceptible to fractures. Without sufficient amounts of vitamin K in the diet, or in cases of Vitamin K deficiency, inactive osteocalcin is not able to bind calcium properly, and thus the bones weaken and become fragile.
Children have the greatest requirement for active osteocalcin and thus for K vitamins because bone tissue grows and develops most intensively during childhood and adolescence. The higher peak mass young bones achieve, the lower the risk of osteoporotic changes in the elderly. Hence, the optimal pubertal status of bone is important to prevent disorders in later life. Knowing that MenaQ7 is the optimal product for achieving good bioavailability of vitamin K2, this study clearly shows that also children will benefit from supplementation with MenaQ7 to improve activation of osteocalcin.
Results of the new study clearly confirm outcomes of previous laboratory experiments, population-based (i.e., epidemiological) studies and clinical trials that have tightly linked better vitamin K status in children to the achievement of a healthy, strong bone-structure. Simplified, improving vitamin K status in children results in stronger and denser bones. Additional K vitamins intake might also improve bone geometry and positively influence gain in bone mass. That contributing effect has been recently reported by O’Connor et al , who, while conducting a study in a cohort of 223 healthy girls (11-12 years old), found better K vitamin status related to higher bone mineral density.
Warfarin, a commonly prescribed blood-thinning medication, inhibits vitamin K activity. A study of children with long-standing vitamin K deficiency induced by this drug were shown to have a significantly reduced bone mass, which illustrates the potential consequences of K vitamins deficiency in growing bones.
